Skip to content
There’s no stopping the march of AI. Unveil massive upskilling programmes for our techies

There’s no stopping the march of AI. Unveil massive upskilling programmes for our techies

A clear siloing of AI technology is developing, and without upskilling India won’t be able to break the US-China duopoly. Only a globally competent labour force will benefit from the free movement regime in services in our trade negotiations. Businesses are seeking locations that aren’t just safe and conducive but also brimming with talent. We shouldn’t miss the AI bandwagon 

Read More

​ A clear siloing of AI technology is developing, and without upskilling India won’t be able to break the US-China duopoly. Only a globally competent labour force will benefit from the free movement regime in services in our trade negotiations. Businesses are seeking locations that aren’t just safe and conducive but also brimming with talent. We shouldn’t miss the AI bandwagon  A clear siloing of AI technology is developing, and without upskilling India won’t be able to break the US-China duopoly. Only a globally competent labour force will benefit from the free movement regime in services in our trade negotiations. Businesses are seeking locations that aren’t just safe and conducive but also brimming with talent. We shouldn’t miss the AI bandwagon   Moneycontrol Latest News Read More  

A clear siloing of AI technology is developing, and without upskilling India won’t be able to break the US-China duopoly. Only a globally competent labour force will benefit from the free movement regime in services in our trade negotiations. Businesses are seeking locations that aren’t just safe and conducive but also brimming with talent. We shouldn’t miss the AI bandwagon 

Britannia shares reach new milestone; analysts see more than 50% upside

Britannia shares reach new milestone; analysts see more than 50% upside

The biscuit-maker’s stock, which has a ‘buy’ rating from 31 analysts, crossed Rs 5,000

Read More

​ The biscuit-maker’s stock, which has a ‘buy’ rating from 31 analysts, crossed Rs 5,000 The biscuit-maker’s stock, which has a ‘buy’ rating from 31 analysts, crossed Rs 5,000  Moneycontrol Latest News Read More  

The biscuit-maker’s stock, which has a ‘buy’ rating from 31 analysts, crossed Rs 5,000

Won#39;t allow unregulated slaughter of animals: Bombay HC

Won#39;t allow unregulated slaughter of animals: Bombay HC

The petition filed by the Hajrat Peer Malik Rehan Mira Saheb Dargah Trust challenged the directive issued by the Deputy Director of Archaeology and Museums, Mumbai on February 1 this year prohibiting illegal animal slaughter in the name of sacrifice to Gods.

Read More

​ The petition filed by the Hajrat Peer Malik Rehan Mira Saheb Dargah Trust challenged the directive issued by the Deputy Director of Archaeology and Museums, Mumbai on February 1 this year prohibiting illegal animal slaughter in the name of sacrifice to Gods. The petition filed by the Hajrat Peer Malik Rehan Mira Saheb Dargah Trust challenged the directive issued by the Deputy Director of Archaeology and Museums, Mumbai on February 1 this year prohibiting illegal animal slaughter in the name of sacrifice to Gods.  Moneycontrol Latest News Read More  

The petition filed by the Hajrat Peer Malik Rehan Mira Saheb Dargah Trust challenged the directive issued by the Deputy Director of Archaeology and Museums, Mumbai on February 1 this year prohibiting illegal animal slaughter in the name of sacrifice to Gods.

CDSL bounces back after stake sale by BSE, rise in demat accounts

CDSL bounces back after stake sale by BSE, rise in demat accounts

The stock had fallen sharply on June 14 after BSE sold a 4.5 percent stake in CDSL. The stock got a boost as 21 lakh demat accounts were opened in May, which is 33 percent more than those in April

Read More

​ The stock had fallen sharply on June 14 after BSE sold a 4.5 percent stake in CDSL. The stock got a boost as 21 lakh demat accounts were opened in May, which is 33 percent more than those in April The stock had fallen sharply on June 14 after BSE sold a 4.5 percent stake in CDSL. The stock got a boost as 21 lakh demat accounts were opened in May, which is 33 percent more than those in April  Moneycontrol Latest News Read More  

The stock had fallen sharply on June 14 after BSE sold a 4.5 percent stake in CDSL. The stock got a boost as 21 lakh demat accounts were opened in May, which is 33 percent more than those in April

Yawning gap: SBI chairman’s Rs 37 lakh salary reignites public vs private banks debate

Yawning gap: SBI chairman’s Rs 37 lakh salary reignites public vs private banks debate

The salary disparity among top executives of public sector and private sector banks have been a subject of debate for years.

Read More

​ The salary disparity among top executives of public sector and private sector banks have been a subject of debate for years. The salary disparity among top executives of public sector and private sector banks have been a subject of debate for years.  Moneycontrol Latest News Read More  

The salary disparity among top executives of public sector and private sector banks have been a subject of debate for years.

Snakes as therapy animals: reptiles help heal in Brazil

Snakes as therapy animals: reptiles help heal in Brazil

Ribeiro has pioneered this method over the past decade at the treatment center, which features an open-air space where patients interact with lizards, turtles and a “jacare” — a kind of alligator native to Latin America that is common in Brazil, including in the Amazon rainforest.

Read More

​ Ribeiro has pioneered this method over the past decade at the treatment center, which features an open-air space where patients interact with lizards, turtles and a “jacare” — a kind of alligator native to Latin America that is common in Brazil, including in the Amazon rainforest. Ribeiro has pioneered this method over the past decade at the treatment center, which features an open-air space where patients interact with lizards, turtles and a “jacare” — a kind of alligator native to Latin America that is common in Brazil, including in the Amazon rainforest.  Moneycontrol Latest News Read More  

Ribeiro has pioneered this method over the past decade at the treatment center, which features an open-air space where patients interact with lizards, turtles and a “jacare” — a kind of alligator native to Latin America that is common in Brazil, including in the Amazon rainforest.

Solara Active Pharma spurts 9% on heavy volumes

Solara Active Pharma spurts 9% on heavy volumes

The stock saw a sharp upmove of 300 percent between March 2020 and July 2021, touching Rs 1,800 as COVID outbreak led to a spike in demand for its main offerings — Ibuprofen, Favipiravir and Gabapentin

Read More

​ The stock saw a sharp upmove of 300 percent between March 2020 and July 2021, touching Rs 1,800 as COVID outbreak led to a spike in demand for its main offerings — Ibuprofen, Favipiravir and Gabapentin The stock saw a sharp upmove of 300 percent between March 2020 and July 2021, touching Rs 1,800 as COVID outbreak led to a spike in demand for its main offerings — Ibuprofen, Favipiravir and Gabapentin  Moneycontrol Latest News Read More  

The stock saw a sharp upmove of 300 percent between March 2020 and July 2021, touching Rs 1,800 as COVID outbreak led to a spike in demand for its main offerings — Ibuprofen, Favipiravir and Gabapentin

Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Trastuzumab is used in the treatment of a particular type of breast cancer — HER2-positive, and the company markets its version in India under the brand name #39;Trumab#39;.

Read More

​ Trastuzumab is used in the treatment of a particular type of breast cancer — HER2-positive, and the company markets its version in India under the brand name #39;Trumab#39;. Trastuzumab is used in the treatment of a particular type of breast cancer — HER2-positive, and the company markets its version in India under the brand name #39;Trumab#39;.  Moneycontrol Latest News Read More  

Trastuzumab is used in the treatment of a particular type of breast cancer — HER2-positive, and the company markets its version in India under the brand name #39;Trumab#39;.

Bain Capital makes $3.2 billion offer for SoftwareOne, board says it#39;s too low

Bain Capital makes $3.2 billion offer for SoftwareOne, board says it#39;s too low

In its response, SoftwareOne board, said the offer “materially undervalues” the company and was not in its best interest or that of the majority of its shareholders.

Read More

​ In its response, SoftwareOne board, said the offer “materially undervalues” the company and was not in its best interest or that of the majority of its shareholders. In its response, SoftwareOne board, said the offer “materially undervalues” the company and was not in its best interest or that of the majority of its shareholders.  Moneycontrol Latest News Read More  

In its response, SoftwareOne board, said the offer “materially undervalues” the company and was not in its best interest or that of the majority of its shareholders.

Buy Britannia Industries; target of Rs 5700: Emkay Global Financial

Buy Britannia Industries; target of Rs 5700: Emkay Global Financial

Emkay Global Financial is bullish on Britannia Industries has recommended buy rating on the stock with a target price of Rs 5700 in its research report dated June 14, 2023.

Read More

​ Emkay Global Financial is bullish on Britannia Industries has recommended buy rating on the stock with a target price of Rs 5700 in its research report dated June 14, 2023. Emkay Global Financial is bullish on Britannia Industries has recommended buy rating on the stock with a target price of Rs 5700 in its research report dated June 14, 2023.  Moneycontrol Latest News Read More  

Emkay Global Financial is bullish on Britannia Industries has recommended buy rating on the stock with a target price of Rs 5700 in its research report dated June 14, 2023.

en_USEnglish